Sydney Rosen, MPA
Research Professor
Boston University School of Public Health
Dept of Global Health

MPA, Harvard University



Sydney Rosen, M.P.A., is a Research Professor in the Department of Global Health and the Center for Global Health & Development of the Boston University School of Public Health and the co-director of the Health Economics and Epidemiology Research Office (HE2RO) of the Wits Health Consortium at the University of the Witwatersrand in Johannesburg, South Africa. In collaboration with HE2RO and colleagues at BUSPH, she leads an interdisciplinary team that is carrying out a set of studies on the effectiveness, costs, and benefits of HIV/AIDS care and treatment interventions. She has also worked on other applied economics projects in the Department, including research on the economics of tuberculosis, antimicrobial resistance, malaria prevention and treatment, and air pollution. Her technical training is in public policy analysis and applied economics. She came to BUSPH in 2001 from the Health Office of the former Harvard Institute for International Development (HIID). Before joining the staff of the Health Office, she managed a set of HIID environmental policy projects in the former Soviet Union. She is also the co-founder and former executive director of WorldTeach, Inc., a nonprofit organization that places volunteer teachers in developing countries. She holds a B.A. from Harvard University and a master's degree from the Kennedy School of Government at Harvard.

Center Faculty Member
Boston University School of Public Health
Center for Global Health & Development



2003 Harvard Business Review: McKinsey Award


Improving Pre-ART to improve linkage and retention to care in HIV high burden countries
09/22/2015 - 07/31/2018 (PI)
Bill and Melinda Gates Foundation

EQUIP Year 2
10/01/2016 - 09/30/2017 (PI)
Right to Care (South Africa) USAID

INROADS: Innovations Research on HIV/AIDS
01/01/2014 - 09/30/2017 (PI)
WITS Health Consortium USAID

Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT-SA Study)
06/19/2012 - 05/31/2017 (PI)
NIH/National Institute of Allergy & Infectious Diseases
5U01AI100015-03

EQUIP
10/01/2015 - 12/31/2016 (PI)
Right to Care (South Africa) USAID

'Associate Award' Costs and Cost Effectiveness of Adult Treatment Delivery in South Africa' under Country Research Activity#GHS-A-00-03-00020-00
01/01/2009 - 12/30/2013 (PI)
U.S. Agency for International Development
AID-674-A-00-09-00018

Tuberculosis clinical Diagnostics Research Consortium (CDRC)
03/08/2010 - 09/29/2011 (PI)
Boston Medical Center Corporation NIH CC

Patient-Level Sustainability of Antiretroviral Therapy for HIV/AIDS in South Africa
03/01/2006 - 12/31/2009 (PI)
Doris Duke Charitable Foundation

Impact of Chronic Morbidity and Mortality on Cocoa Production in Ghana
05/15/2004 - 10/31/2005 (PI)
Academy for Educational Development USAID




Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Long LC, Maskew M, Brennan AT, Mongwenyana C, Nyoni C, Malete G, Sanne I, Fox MP, Rosen S. Initiating antiretroviral therapy for HIV at a patient''s first clinic visit: a cost-effectiveness analysis of the rapid initiation of treatment randomized controlled trial. AIDS. 2017 Jul 17; 31(11):1611-1619.View Related Profiles. PMID: 28463879; DOI: 10.1097/QAD.0000000000001528;.
  2. Bor J, Ahmed S, Fox MP, Rosen S, Meyer-Rath G, Katz IT, Tanser F, Pillay D, Bärnighausen T. Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: An empirical modeling study. PLoS One. 2017; 12(6):e0178249.View Related Profiles. PMID: 28617805.
  3. Rosen S, Fox MP, Larson BA, Brennan AT, Maskew M, Tsikhutsu I, Bii M, Ehrenkranz PD, Venter WF. Simplified clinical algorithm for identifying patients eligible for immediate initiation of antiretroviral therapy for HIV (SLATE): protocol for a randomised evaluation. BMJ Open. 2017 May 28; 7(5):e016340.View Related Profiles. PMID: 28554939; DOI: 10.1136/bmjopen-2017-016340;.
  4. Fox MP, Rosen S. A new cascade of HIV care for the era of "treat all". PLoS Med. 2017 Apr; 14(4):e1002268.View Related Profiles. PMID: 28399160; DOI: 10.1371/journal.pmed.1002268;.
  5. Jamieson L, Evans D, Brennan AT, Moyo F, Spencer D, Mahomed K, Maskew M, Long L, Rosen S, Fox MP. Changes in elevated cholesterol in the era of tenofovir in South Africa: risk factors, clinical management and outcomes. HIV Med. 2017 Mar 23.View Related Profiles. PMID: 28332270; DOI: 10.1111/hiv.12495;.
  6. Long LC, Rosen SB, Brennan A, Moyo F, Sauls C, Evans D, Modi SL, Sanne I, Fox MP. Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa. PLoS One. 2016; 11(12):e0168118.View Related Profiles. PMID: 27942005; DOI: 10.1371/journal.pone.0168118;.
  7. Berhanu R, Schnippel K, Mohr E, Hirasen K, Evans D, Rosen S, Sanne I. Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study. PLoS One. 2016; 11(11):e0164974. PMID: 27812140; DOI: 10.1371/journal.pone.0164974;.
  8. Gama E, Madan J, Langley I, Girma M, Evans D, Rosen S, Squire SB. Economic evaluation of a shortened standardised treatment regimen of antituberculosis drugs for patients with multidrug-resistant tuberculosis (STREAM): study protocol. BMJ Open. 2016 Oct 17; 6(10):e014386. PMID: 27798041; DOI: 10.1136/bmjopen-2016-014386;.
  9. Budgell EP, Evans D, Schnippel K, Ive P, Long L, Rosen S. Outcomes of treatment of drug-susceptible tuberculosis at public sector primary healthcare clinics in Johannesburg, South Africa: A retrospective cohort study. S Afr Med J. 2016 Sep 05; 106(10):1002-1009. PMID: 27725021; DOI: 10.7196/SAMJ.2016.v106i10.10745;.
  10. Rosen S, Fox MP, Larson BA, Sow PS, Ehrenkranz PD, Venter F, Manabe YC, Kaplan J. Accelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research Agenda. PLoS Med. 2016 Aug; 13(8):e1002106.View Related Profiles. PMID: 27505444; PMCID: PMC4978457; DOI: 10.1371/journal.pmed.1002106;.
Showing 10 of 63 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 63 publications over 16 distinct years, with a maximum of 9 publications in 2016

YearPublications
20022
20032
20042
20052
20061
20076
20085
20091
20107
20113
20124
20137
20144
20153
20169
20175
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Antiretroviral therapy
Cost-effectiveness analysis
Health economics
HIV
South Africa
Contact for Mentoring:


801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map


Rosen's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department